Extended formulations, nonnegative factorizations, and randomized communication protocols

An extended formulation of a polyhedron P is a linear description of a polyhedron Q together with a linear map π such that π(Q)=P. These objects are of fundamental importance in polyhedral combinatorics and optimization theory, and the subject of a number of studies. Yannakakis’ factorization theorem (Yannakakis in J Comput Syst Sci 43(3):441–466, 1991) provides a surprising connection between extended formulations and communication complexity, showing that the smallest size of an extended formulation of $$P$$P equals the nonnegative rank of its slack matrix S. Moreover, Yannakakis also shows that the nonnegative rank of S is at most 2^c, where c is the complexity of any deterministic protocol computing S. In this paper, we show that the latter result can be strengthened when we allow protocols to be randomized. In particular, we prove that the base-2 logarithm of the nonnegative rank of any nonnegative matrix equals the minimum complexity of a randomized communication protocol computing the matrix in expectation. Using Yannakakis’ factorization theorem, this implies that the base-2 logarithm of the smallest size of an extended formulation of a polytope P equals the minimum complexity of a randomized communication protocol computing the slack matrix of P in expectation. We show that allowing randomization in the protocol can be crucial for obtaining small extended formulations. Specifically, we prove that for the spanning tree and perfect matching polytopes, small variance in the protocol forces large size in the extended formulation.

Potencial cariogénico de medicamentos pediátricos

A cárie dentária é uma doença infeciosa, transmissível e multifatorial e é também a doença mais prevalente na cavidade oral das crianças. A grande maioria dos medicamentos desenvolvidos para a Pediatria tem na sua composição algum tipo de açúcar, de forma a tornar a sua ingestão mais agradável, o que lhes confere um potencial cariogénico agravado nesta faixa etária. A sacarose continua a ser o açúcar mais utilizado por ser de baixo custo, ser antioxidante e conferir viscosidade ao medicamento. O potencial cariogénico dos medicamentos está relacionado com vários fatores como a presença de sacarose, o seu pH endógeno, a viscosidade, a frequência de ingestão, o momento de ingestão, a capacidade de causar xerostomia e os hábitos de higiene oral individuais. Por parte dos Médicos Dentistas e Pediatras é necessário aconselhar os responsáveis das crianças dos riscos e cuidados a ter durante a toma dos medicamentos incluindo exames dentários regulares. Por parte da Indústria Farmacêutica é necessário o desenvolvimento de formulações livres de açúcar ou com edulcorantes não cariogénicos. O objetivo deste trabalho foi esclarecer a relação entre a cárie dentária e os medicamentos pediátricos, enfatizando a necessidade do planeamento de ações no sentido de prevenir o desenvolvimento da doença. Para tal foi realizada uma revisão sistemática da literatura, através de pesquisa bibliográfica nos bancos de dados Medline, Pubmed, B-On e Scielo e Science Direct.

Strategic divide management in pharmaceutical alliances: A partner’s strategic evolution as a reason for strategic divide

Strategic alliances are widely used in the pharmaceutical industry and, ideally, they are long-lasting structures that bring many benefits and value to the alliance partners. However, organizations continuously encounter pressures to enhance performance, while the environment in which they operate evolves. Therefore, an alliance partner might be forced to change its strategy, which can lead to the partners’ misaligned priorities and strategic divide. The academic literature acknowledges the impact a partner’s strategic change can have on the value of the alliance, but the phenomenon is not studied further, which is why the purpose of this study is to understand the role that a partner’s strategic evolution plays in strategic alliances within the pharmaceutical industry. The main purpose is further divided into three sub-objectives: 1) Describe reasons behind the strategic direction change of a partner firm, 2) Understand the consequences of partners’ misaligned priorities, and 3) Describe proactive and reactive ways to manage strategic divide between alliance partners. Since the phenomenon is not studied much, the empirical part of the study was conducted as a qualitative analysis using expert interviews to better understand, how the partner’s strategic evolution affects the alliance. The empirical data was organized into themes, according to the researcher’s interpretations on the interviews. The research findings demonstrated, how the partners change their strategies if the external or organizational environments change. The strategic changes, again, cause strategic divides between the alliance partners that are likely to have an impact on the alliance value. The findings revealed that the interviewees consider anticipation of the partner’s strategic change to be really difficult, but, at the same time, it was noted that a proactive strategic divide management could help to prevent and detect some divides. Additionally, the results showed that, after the detection, a reactive approach in a controlled manner was seen to be the most beneficial for the alliance’s future performance. This study proved that a partner’s strategic evolution affects the partners’ priority alignment and alliance value, which is why the strategic divide management is important in organizations that are involved with strategic alliances. In order to understand the role of a partner’s strategic evolution and provide managers with a tool to manage alliances and strategic divides, the study combined the alliance lifecycle as well as the proactive and reactive approaches to strategic divide, and presented a framework for strategic divide management.

A Multi-Objective Approach for VNE: Problems using multiple ILP formulations

Network Virtualization is a key technology for the Future Internet, allowing the deployment of multiple independent virtual networks that use resources of the same basic infrastructure. An important challenge in the dynamic provision of virtual networks resides in the optimal allocation of physical resources (nodes and links) to requirements of virtual networks. This problem is known as Virtual Network Embedding (VNE). For the resolution of this problem, previous research has focused on designing algorithms based on the optimization of a single objective. On the contrary, in this work we present a multi-objective algorithm, called VNE-MO-ILP, for solving dynamic VNE problem, which calculates an approximation of the Pareto Front considering simultaneously resource utilization and load balancing. Experimental results show evidences that the proposed algorithm is better or at least comparable to a state-of-the-art algorithm. Two performance metrics were simultaneously evaluated: (i) Virtual Network Request Acceptance Ratio and (ii) Revenue/Cost Relation. The size of test networks used in the experiments shows that the proposed algorithm scales well in execution times, for networks of 84 nodes

A new insight about pharmaceutical dosage forms for benzathine penicillin G

In this work, a micellar system of benzathine penicillin G (BPG) in sodium deoxycholate (NaDC) was developed and evaluated physicochemically. The solubility profile of the drug in water and buffer solutions at various pH was determined, as well as its n-octanol/water partition coefficient. The Critical Micellar Concentration of NaDC and its ability to incorporate BPG were also assessed. The study was carried out at low and high ionic strength which was adjusted by the addition of sodium chloride. The results demonstrated the ability of the micellar system to incorporate BPG, as well as to increase its apparent solubility in water. The enhancement of the solubility of BPG by the presence of NaDC micelles could be analyzed quantitatively within the framework of the pseudo-phase model. Concentration analysis showed that the micellar system could attain up to 90% incorporation of BPG. The incorporated drug is expected to exhibit improved stability, since the antibiotic enclosed in the hydrophobic core of micelles is rather shielded from the aqueous external environment

Produção de biossurfactantes e nanoemulsões a partir da microalga spirulina

As microalgas têm sido foco de muitos estudos tendo em vista sua grande aplicabilidade na indústria de alimentos e farmacêutica, como também nas áreas da biomedicina e ambiental. A Spirulina é uma microalga que possui alto valor nutricional, apresenta alto teor proteico e é rica em substâncias bioativas. Esta microalga apresenta em sua composição compostos como glicolípidios, fosfolipídios e lipídios neutros, que por sua vez possuem efeito biossurfactante. Assim, o objetivo deste estudo foi verificar a potencialidade de produção de biossurfactantes a partir de diferentes cepas de Spirulina. Para isso, foram realizados experimentos utilizando Delineamento Fatorial Completo 22 , visando avaliar a influência da concentração de fósforo e nitrogênio no cultivo das microalgas Spirulina platensis Paracas, Spirulina platensis LEB 52 e Spirulina sp. LEB 18, como também nos extratos oriundos das microalgas, através da medida da tensão superficial. Foi também avaliada a influência destes nutrientes em extratos de Spirulina platensis LEB 52 e Spirulina sp. LEB 18 a partir do índice de emulsificação e diâmetro médio das gotículas das emulsões preparadas a partir dos extratos. Para extrações de biossurfactantes foram testados os solventes metanol, etanol e hexano. Nas formulações das nanoemulsões utilizou-se homogeneizador de alta velocidade, como fase aquosa os extratos oriundos das microalgas e como fase oleosa, óleo de girassol. As formulações foram preparadas utilizando-se diferentes concentrações da fase aquosa e oleosa, bem como diferentes velocidades e tempos de agitação. De acordo com os cultivos de Spirulina platensis Paracas realizados foi verificado que o cultivo que atingiu maior valor de concentração máxima de biomassa e maior produtividade foi realizado com 114 mg.L-1 de fósforo e sem adição de nitrogênio. Porém em relação às microalgas Spirulina platensis LEB 52 e Spirulina sp. LEB 18, as variáveis fósforo e nitrogênio não apresentaram influência significativa na concentração máxima de biomassa e produtividade máxima. O extrato que apresentou a menor tensão superficial (26,75 mN.m-1 ) foi verificado quando foi utilizado etanol como solvente, sendo este obtido a partir de cultivo da microalga Spirulina sp. LEB 18 realizado sem adição de nitrogênio e de fósforo. Em relação ao índice de emulsificação foram atingidos valores superiores a 59%, porém as concentrações utilizadas de nitrogênio e fósforo não apresentaram influência significativa nesta resposta. Neste trabalho foi possível obter nanoemulsões estáveis por até 30 d e com diâmetro médio de gotículas de até 532 nm. Os resultados obtidos neste trabalho são favoráveis à pesquisa na aplicação tanto dos extratos microalgais como das nanoemulsões obtidas apresentando potencialidade de uso em diversos processos industriais, como nas áreas ambiental, farmacêutica, cosmética e alimentos.

Refocusing regulatory exclusivities: Regulatory data protection and marketing exclusivity as forms of pharmaceutical innovation policy

Protection of innovation in the pharmaceutical industry has traditionally been realised through protection of inventions via patents. However, in the European Union regulatory exclusivities restricting market entry of generic products confer tailored, industry specific protection for final, marketable products. This paper retraces the protection conferred by the different forms of exclusivity and assesses them in the light of recent transparency policies of the European Medicines Agency. The purpose of the paper is to argue for rethinking the role of regulatory data as a key tool of innovation policy and for refocusing the attention from patents to the existing regulatory framework. After detailed assessment of the exclusivity regime, the paper identifies key areas of improvement calling for reassessment so as to promote better functioning of the regime as an incentive for accelerated innovation. While economic and public health analysis necessarily provide final answers as to necessity of reform, this paper provides a legal perspective to the issue, appraising the current regulatory framework and identifying areas for further analysis.

A New Journal in the Field of Pharmaceutical Technology Is Born

International audience

Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas

International audience

Design and stability study of a paediatric oral solution of methotrexate 2mg/ml

International audience

Organizational configuration, fit and performance: The case of the pharmaceutical industry in Portugal

Miles e Snow’s configurational theory has received a great deal of attention from many investigators. Framing the Miles e Snow Typology with the organizational configuration concept, the main purpose of this paper is to make an empirical evaluation of what configurational theories postulate: higher organizational performance is associated to the resemblance to one of the ideal types defined. However, as it is often assumed that an organization can increase performance by selecting the adjustable hybrid type to its own exogenous environment, the relation between the organization’s effectiveness and the hybrid configuration alignment to the respective specific environment types was also analyzed. The assumption of equifinality was also considered because the configurational theory assumes that all the ideal types can potentially achieve the same performance level. A multiple regression model was made to confirm if the misfit related to the ideal and hybrid types has significant impact on the organizational effectiveness. The analysis of variance and the Kruskal-Wallis test were used to verify the equality of performance between the different organization types. In short, the empirical results obtained confirm what is postulated in the theory.

Analysis of β-tricalcium phosphate granules prepared with different formulations by nano-computed tomography and scanning electron microscopy

International audience

25 years of knowledge creation processes in pharmaceutical contemporary trends

The pharmaceutical industry is knowledge and research-intensive. Due to technological, socio-political and organisational changes there has been a continuous evolution in the knowledge base utilized to achieve and maintain competitive advantages in this global industry. There is a gap in analysing the linkages and effects of those changes on knowledge creation processes associated with pharmaceutical R&D activities. Our paper looks to fill this gap. We built on an idiosyncratic research approach – the systematic literature review – and looked to unearth current trends affecting knowledge creation in international/global pharmaceutical R&D. We reviewed scientific papers published between 1980 and 2005. Key findings include promising trends in pharmaceutical innovation and human resource management, and their potential implications on current R&D practices within the pharmaceutical industry, from managerial and policy-making perspectives.